Regular Article
Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides

https://doi.org/10.1006/exnr.2001.7541Get rights and content

Abstract

Apolipoprotein E plays an important role in recovery from acute brain injury and risk of developing Alzheimer's disease. We demonstrate that biologically relevant concentrations of apoE suppress microglial activation and release of TNFα and NO in a dose-dependent fashion. Peptides derived from the apoE receptor-binding region mimic the effects of the intact protein, whereas deletion of apoE residues 146–149 abolishes peptide bioactivity. These results are consistent with the hypothesis that apoE modulates microglial function by binding specific cell surface receptors and that the immunomodulatory effects of apoE in the central nervous system may account for its role in acute and chronic neurological disease.

References (73)

  • T.L. Innerarity et al.

    Normalization of receptor binding of apolipoprotein E2: Evidence for modulation of the binding site conformation

    J. Biol. Chem.

    (1984)
  • N. Janabi et al.

    Establishment of human microglial cell lines after transfection of primary cultures with SV40 large T antigen

    Neurosci. Lett.

    (1995)
  • D-H. Kim et al.

    Human apolipoprotein E receptor 2

    J. Biol. Chem.

    (1996)
  • A. Lalazar et al.

    Site-specific mutagenesis of human apolipoprotein E

    J. Biol. Chem

    (1988)
  • D.T. Laskowitz et al.

    Altered immune responses in apolipoprotein E deficient mice

    J. Lipid Res.

    (2000)
  • D.T. Laskowitz et al.

    Apolipoprotein E suppresses glial cell secretion of TNFα

    J. Neuroimmunol.

    (1997)
  • F. Licastro et al.

    Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE genotype

    J. Neuroimmunol.

    (1998)
  • R.T. Matthews et al.

    Increased 3-nitrotyrosine in brains of Apo E-deficient mice

    Brain Res.

    (1996)
  • S. Novak et al.

    A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse

    J. Biol. Chem.

    (1996)
  • R.E. Pitas et al.

    Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

    Biochim. Biophys. Acta

    (1987)
  • S.E. Roselaar et al.

    Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo

    J. Lipid Res.

    (1998)
  • B.E. Tardiff et al.

    Preliminary report of a genetic basis for cognitive decline after cardiac operations: The Neurologic Outcome Research Group of the Duke Heart Center

    Ann. Thorac. Surg.

    (1997)
  • G.M. Teasdale et al.

    Association of apolipoprotein E polymorphism with outcome after head injury

    Lancet

    (1997)
  • K.H. Weisgraber et al.

    Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site

    J. Biol. Chem.

    (1982)
  • K.H Weisgraber

    Apolipoprotein E: Structure–function relationships

    Adv. Protein Chem.

    (1994)
  • S.W. Barger et al.

    Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

    Nature

    (1997)
  • V. Bocchini et al.

    An immortalized cell line expresses properties of activated microglial cells

    J. Neurosci. Res.

    (1992)
  • M.A. Clay et al.

    Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity

    Biochmeistry

    (1995)
  • D. Clayton et al.

    NMR Studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles

    Protein Sci.

    (1999)
  • C. Colton et al.

    Species differences in the generation of reactive oxygen species by microglia

    Mol. Chem. Neuropathol.

    (1996)
  • E.H. Corder et al.

    Gene doses of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

    Science

    (1993)
  • L.K. Curtiss et al.

    The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content

    J. Immunol.

    (1981)
  • T.S. Edgington et al.

    Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response

    Cancer Res.

    (1981)
  • R. Ensperger et al.

    Microglial activation in Alzheimer disease: Association with APOE genotype

    Brain Pathol.

    (1998)
  • G. Friedman et al.

    Apolipoprotein E-epsilon 4 genotype predicts a poor outcome in survivors of traumatic brain injury

    Neurology

    (1999)
  • G. Gallo et al.

    Potential role of apolipoprotein-E in fibrillogenesis

    Am. J. Pathol.

    (1994)
  • Cited by (0)

    View full text